Blue-Chip

What market expects from December ASX Index rebalance?

October 11, 2017 | Team Kalkine
What market expects from December ASX Index rebalance?

The December ASX Index rebalance is expected to bring some key changes that echo the stock movements seen on ASX lately.
Particularly, ASX has seen Australian shares falling for the first time in three sessions at the back of impact from big miners where short selling is seen as a trend (for example short positions in Rio were stated to have moved up to 9%). Further, S&P/ASX 200 Index was seen to drop marginally on October 10 and this slashed the year’s rise to 1.2%. Primarily, a lot of movements is seen in shares of many blue-chips and mid-caps with some small companies now moving to a better position. For instance, shares of Commonwealth Bank of Australia have been slipping in anticipation of bank dropping its internal return on equity targets at the back of the recent regulatory debacle related to Austrac allegations. On the other hand, AMP shares have seen some sunshine with rating upgrade by brokers post underperforming the market for few months based on its first half 2017 results. Platinum Asset Management also added to gains with its improving funds under management position.

The key stock that has grabbed a lot of attention lately is A2 Milk Company and the market now expects A2 Milk to be sitting in the top 100 while Vocus or Tatts Group may be out given the 3-month run-up of about 88% for A2M shares.

The 200 index is expected to see the additions of Pilbara Minerals, Wisetech Global and Lynas Corp while FlexiGroup, Japara Healthcare, Regis Healthcare or Tatts are seen as candidates that might be ousted. Amcor is also expected to take a position in the top 20 while Cochlear can move in top 50 replacing Incitec Pivot. Further, the Tabcorp and Tatts merger development is closely watched that can also bring changes with respect to the rebalance.


Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.